Related Experiment Videos
Adjuvant oral Razoxane (ICRF 159) in resectable colo-rectal cancer
Cancer Chemotherapy and Pharmacology
|January 1, 1983
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox II.
Annals of oncology : official journal of the European Society for Medical Oncology·2013
A feasibility, pharmacokinetic and frequency-escalation trial of intraperitoneal chemotherapy in high risk gastrointestinal tract cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2007
Clinical aspects of a phase I trial of 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent.
British journal of cancer·2003
Irinotecan, cisplatin and mitomycin in inoperable gastro-oesophageal and pancreatic cancers - a new active regimen.
British journal of cancer·2002
Limited phase I study of morphine-3-glucuronide.
Journal of pharmaceutical sciences·2001
Intensification versus combination: revisiting the past and envisioning the future of LDHA inhibitors.
Cancer chemotherapy and pharmacology·2026
Circulatory compromise as a potential mechanism of fatal hepatic failure during long-term selpercatinib therapy: pharmacokinetic and clinical insights.
Cancer chemotherapy and pharmacology·2026
CDCP1-targeted antibody-drug conjugates and immunocytokines for cancer therapy.
Cancer chemotherapy and pharmacology·2026
Pharmacokinetic and pharmacodynamic sub-study of trans-arterial vs. intravenous gemcitabine in the TIGeR-PaC phase 3 clinical trial.
Cancer chemotherapy and pharmacology·2026
A phase 1, open-label study evaluating the pharmacokinetics, safety, and tolerability of vepdegestrant in Chinese patients with ER+/HER2- advanced breast cancer.
Cancer chemotherapy and pharmacology·2026
Quantitative characterization of platelet count and alanine aminotransferase dynamics to inform personalized dosing in the first-in-human LP-184 trial.
Cancer chemotherapy and pharmacology·2026
Cost‑effectiveness of first‑line immunotherapy-based combination regimens for advanced renal cell carcinoma in China and the United States.
Human vaccines & immunotherapeutics·2026
CD7 CAR-T cells eliminate chronic myeloid leukemia stem cells specifically and effectively.
Hematology (Amsterdam, Netherlands)·2026
Impact of Immunotherapy Prescribing Restrictions on Time to Systemic Therapy and Outcomes in Metastatic Clear Cell Renal Carcinoma in Australia.
Asia-Pacific journal of clinical oncology·2026